Skip to main content
TipRanks
Go Ultimate75% OFF

Ab&B Bio-Tech CO., LTD. JS Class H (2627) Stock Price & Analysis

2 Followers

2627 Stock Chart & Stats

HK$29.32HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$40HK$60Jan 5Jan 19Feb 2Feb 16Mar 2Mar 16Mar 30
Day’s Range
HKD 28.88 - HKD 30.46
52-Week Range
HKD 28.88 - HKD 73.00
Previous Close
HKD 29.32
Volume
N/A
Average Volume (3M)
0
Market Cap
HKD 11.54B
Enterprise Value
HKD 9927.78T
Total Cash (Recent Filing)
HKD 108.36M
Total Debt (Recent Filing)
HKD 931.93M
Price to Earnings (P/E)
―
Beta
1.32
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong 2024 Revenue Rebound And Gross Margin Recovery

A large revenue rebound coupled with a dramatic gross margin swing indicates the business achieved meaningful pricing, mix or cost improvements. These changes improve the path to durable operating leverage and reduce the scale of revenue needed to reach sustainable profitability over the next several quarters.

Positive Equity Buffer On The Balance Sheet

Maintaining positive equity gives the company a capital cushion that reduces immediate insolvency risk and supports continued operations or negotiations with creditors. This structural buffer preserves strategic optionality for refinancing, partnerships, or asset-backed funding over 2–6 months.

Operating In Specialty & Generic Pharmaceuticals

Participation in the specialty & generic drugs sector offers durable demand drivers and product differentiation opportunities. Regulatory and manufacturing barriers in this industry can create sustainable competitive advantages for proven products, supporting longer-term revenue visibility and strategic partnerships.

Bears Say

Persistent Unprofitable Operations And Material Cash Burn

Ongoing operating losses and structural cash burn impair the company’s ability to self-fund growth or R&D. Without sustained margin expansion, the firm will remain dependent on external financing, increasing dilution risk and reducing strategic flexibility over the coming months.

Very Weak Cash Generation And Negative Free Cash Flow

Large negative operating and free cash flows indicate operations are not generating internal funding for capex or commercialization. This structural cash shortfall forces ongoing reliance on debt or equity raises, constraining long-term reinvestment and raising execution risk.

Elevated Leverage And Rising Debt Load

A very high debt-to-equity ratio and a sharp rise in debt reduce financial flexibility and elevate interest and covenant risk. With continued losses, leverage amplifies downside, limits strategic options, and increases the probability of distress or restrictive financing terms over the medium term.

Ab&B Bio-Tech CO., LTD. JS Class H News

2627 FAQ

What was Ab&B Bio-Tech CO., LTD. JS Class H’s price range in the past 12 months?
Ab&B Bio-Tech CO., LTD. JS Class H lowest stock price was HK$28.88 and its highest was HK$73.00 in the past 12 months.
What is Ab&B Bio-Tech CO., LTD. JS Class H’s market cap?
Ab&B Bio-Tech CO., LTD. JS Class H’s market cap is HK$11.54B.
When is Ab&B Bio-Tech CO., LTD. JS Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ab&B Bio-Tech CO., LTD. JS Class H’s earnings last quarter?
Ab&B Bio-Tech CO., LTD. JS Class H released its earnings results on Aug 28, 2025. The company reported -HK$0.094 earnings per share for the quarter.
Is Ab&B Bio-Tech CO., LTD. JS Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Ab&B Bio-Tech CO., LTD. JS Class H pay dividends?
Ab&B Bio-Tech CO., LTD. JS Class H does not currently pay dividends.
What is Ab&B Bio-Tech CO., LTD. JS Class H’s EPS estimate?
Ab&B Bio-Tech CO., LTD. JS Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ab&B Bio-Tech CO., LTD. JS Class H have?
Ab&B Bio-Tech CO., LTD. JS Class H has 296,361,850 shares outstanding.
What happened to Ab&B Bio-Tech CO., LTD. JS Class H’s price movement after its last earnings report?
Ab&B Bio-Tech CO., LTD. JS Class H reported an EPS of -HK$0.094 in its last earnings report. Following the earnings report the stock price went down -1.013%.
Which hedge fund is a major shareholder of Ab&B Bio-Tech CO., LTD. JS Class H?
Currently, no hedge funds are holding shares in HK:2627
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology